U.S. Complex & Chronic Condition Management Market (By Disease Type: Cardiovascular Diseases, Oncology, Musculoskeletal, Women’s Health/Fertility/Maternity, Chronic Obstructive Pulmonary Disease, Others; By Service: Consulting Service, Implementation Service, Education Service, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2027

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Complex & Chronic Condition Management Market 

5.1. COVID-19 Landscape: Complex & Chronic Condition Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Complex & Chronic Condition Management Market, By Disease

8.1. Complex & Chronic Condition Management Market, by Disease Type, 2021-2027

8.1.1. Cardiovascular Diseases

8.1.1.1. Market Revenue and Forecast (2017-2027)

8.1.2. Oncology

8.1.2.1. Market Revenue and Forecast (2017-2027)

8.1.3. Musculoskeletal

8.1.3.1. Market Revenue and Forecast (2017-2027)

8.1.4. Women’s Health/Fertility/Maternity

8.1.4.1. Market Revenue and Forecast (2017-2027)

8.1.5. Chronic Obstructive Pulmonary Disease

8.1.5.1. Market Revenue and Forecast (2017-2027)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2027)

Chapter 9. U.S. Complex & Chronic Condition Management Market, By Service

9.1. Complex & Chronic Condition Management Market, by Service, 2021-2027

9.1.1. Consulting Service

9.1.1.1. Market Revenue and Forecast (2017-2027)

9.1.2. Implementation Service

9.1.2.1. Market Revenue and Forecast (2017-2027)

9.1.3. Education Service

9.1.3.1. Market Revenue and Forecast (2017-2027)

9.1.3.2.

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2027)

Chapter 10. U.S. Complex & Chronic Condition Management Market, U.S. Estimates and Trend Forecast

10.1. U. S.

10.1.1. Market Revenue and Forecast, by Disease (2017-2027)

10.1.2. Market Revenue and Forecast, by Service (2017-2027)

Chapter 11. Company Profiles

11.1. AllScripts

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Siemens Healthineers

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Koninklijke Philips N.V.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Pegasystems, Inc.

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Cognizant TriZetto Software Group Inc.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. IBM Corporation

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. ScienceSoft USA

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. MINES & Associates, Inc.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Healthcare at Home

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Mediware Information Systems

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

PROCEED TO BUY

   USD 4500.00
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample